Clinical Trial Update: Clinical Efficacy and Mechanism Exploration of MR-61 in Delaying the Progression of Myopia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating MR-61 for delaying the progression of myopia. The study is currently recruiting and includes exploration of the drug's mechani…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• MR-61

Snippet

Sponsor: Second Affiliated Hospital of Nanchang University | Conditions: Myopia Progressing | Phase 2 | Status: RECRUITING